Status: current, Defined. Date: 30-Sep 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4189421000168116 | leuprorelin acetate 22.5 mg modified release injection, 22.5 mg chamber (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4189431000168118 | leuprorelin acetate 22.5 mg modified release injection, chamber | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| leuprorelin acetate 22.5 mg modified release injection, chamber | Is a | leuprorelin | true | Inferred relationship | Some | ||
| leuprorelin acetate 22.5 mg modified release injection, chamber | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| leuprorelin acetate 22.5 mg modified release injection, chamber | has manufactured dose form | modified release injection | true | Inferred relationship | Some | ||
| leuprorelin acetate 22.5 mg modified release injection, chamber | has unit of use | chamber | true | Inferred relationship | Some | 418549021 | |
| leuprorelin acetate 22.5 mg modified release injection, chamber | has intended active ingredient | leuprorelin | true | Inferred relationship | Some | 418549020 | |
| leuprorelin acetate 22.5 mg modified release injection, chamber | has Australian BoSS | leuprorelin acetate | true | Inferred relationship | Some | 418549020 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lucrin Depot 3-Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg chamber | Is a | True | leuprorelin acetate 22.5 mg modified release injection, chamber | Inferred relationship | Some | |
| leuprorelin acetate 22.5 mg modified release injection [1 chamber] (&) inert substance diluent [1.5 mL chamber], 1 dual chamber syringe | has MPUU | True | leuprorelin acetate 22.5 mg modified release injection, chamber | Inferred relationship | Some | 1 |
Reference Sets
List of Medicines for Brand Consideration reference set
Medicinal product unit of use reference set
FHIR